Cencora (COR) vs EnerSyn Global (ESYN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cencora (COR) has outperformed EnerSyn Global (ESYN) over the past year, losing 7.3% versus a loss of 26.5%. Cencora is the larger company by market cap ($64.71 billion vs $37.4 million), about 1728.5 times the size. Cencora pays a dividend yielding 0.71%, while EnerSyn Global does not currently pay one.
Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -303.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | ESYN |
|---|---|---|
| Share price | $339.09 | $1.11 |
| Market cap | $64.71B | $37.44M |
| 1-day change | -0.63% | -0.89% |
| YTD return | +0.40% | -25.50% |
| 1-year return | -7.27% | -26.49% |
| 5-year return | +182.03% | — |
| P/E ratio (TTM) | 18.89 | — |
| Forward P/E | 15.60 | — |
| EPS (TTM) | $17.95 | $-0.58 |
| Dividend yield | 0.71% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $321.33B | $866.93K |
| Revenue growth (YoY) | +9.31% | -30.84% |
| Net income (latest FY) | $1.55B | $-2.63M |
| Gross margin | 3.57% | 53.03% |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | -303.44% |
| 52-week high | $377.54 | $2.81 |
| 52-week low | $244.82 | $0.88 |
| Distance from 52-week high | -10.18% | -60.50% |
| Analyst consensus | buy | — |
| Avg. price target upside | +12.78% | — |
| Average volume | 1.29M | 38.17K |
| Shares outstanding | 190.83M | 33.73M |
| Employees | 47,000 | 4 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 1728.5 times larger than EnerSyn Global by market value ($64.71B vs $37.44M).
- COR has outperformed ESYN by 19.2 percentage points over the past year.
- Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
- Cencora grew revenue faster in its latest fiscal year (+9.31% vs -30.84%).
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
About EnerSyn Global
ESYN stock →EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.
Health Care · Other Pharmaceuticals · 4 employees
COR vs ESYN FAQ
Which is bigger, Cencora or EnerSyn Global?
Cencora (COR) is larger, with a market capitalization of $64.71B compared with $37.44M for EnerSyn Global (ESYN).
Which stock has performed better over the past year, COR or ESYN?
COR returned -7.27% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cencora or EnerSyn Global?
Cencora pays a dividend yielding 0.71%, while EnerSyn Global does not currently pay a regular dividend.
Are Cencora and EnerSyn Global in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.